Home › Johnson & Johnson: Drug clears more psoriasis than rival's
 

Keywords :   


Johnson & Johnson: Drug clears more psoriasis than rival's

2015-07-09 01:37:37| Biotech - Topix.net

A study funded by drugmaker Johnson & Johnson indicates its experimental psoriasis medicine works better than a rival drug that dominates the market for biologic drugs for immune disorders. The J&J drug, guselkumab, is now in its final stage of patient testing and in a couple of years likely will join other recent treatments that offer big improvements for the millions of patients with the common, painful skin disorder.

Tags: than drug johnson rivals

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.06Tropical Storm Beryl Graphics
29.06Tropical Storm Beryl Forecast Discussion Number 2
29.06Tropical Storm Beryl Public Advisory Number 2
29.06Summary for Tropical Storm Beryl (AT2/AL022024)
29.06Tropical Storm Beryl Wind Speed Probabilities Number 2
29.06Tropical Storm Beryl Forecast Advisory Number 2
29.06Atlantic Tropical Weather Outlook
29.06Eastern North Pacific Tropical Weather Outlook
More »